Search

Your search keyword '"Lubomir Skladany"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Lubomir Skladany" Remove constraint Author: "Lubomir Skladany"
41 results on '"Lubomir Skladany"'

Search Results

1. Acute Kidney Injury after Liver Transplantation

2. Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes

3. Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection

4. Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis

5. Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course

6. Non-alcoholic fatty liver disease after liver transplantation: A lifestyle reloaded

7. Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

10. A multi-society Delphi consensus statement on new fatty liver disease nomenclature

11. The impact of alcohol consumption on the quality of life of college students: a study from three Slovak universities

12. A multi-society Delphi consensus statement on new fatty liver disease nomenclature

13. Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review

14. Questionnaire for risk factors of alcoholic and nonalcoholic fatty liver disease

15. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context

16. Adherence to Oral Nutritional Supplements After Being Discharged from the Hospital is Low but Improves Outcome in Patients with Advanced Chronic Liver Disease

17. Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine

19. Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes

20. Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course

21. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival—A Retrospective Analysis of a Slovak Cohort

22. Inflammatory Indexes as Prognostic Factors of Survival in Geriatric Patients with Hepatocellular Carcinoma: A Case Control Study of Eight Slovak Centers

23. Hepatitis C virus antibodies in outpatients with chronic kidney disease

24. Applicability and prognostic value of frailty assessment tools among hospitalized patients with advanced chronic liver disease

25. Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis

26. Irisin in Liver Cirrhosis

27. DE NOVO NON-ALCOHOLIC FATTY LIVER DISEASE AFTER LIVER TRANSPLANTATION IN SMALL LIVER TRANSPLANT CENTRE IN SLOVAKIA

28. Alcohol Use Relapse Following Liver Transplantation for Alcoholic Liver Disease

29. Liver transplantation in Central Europe

31. Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

32. Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population

35. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis

36. Nanocrystalline cerium dioxide efficacy for prophylaxis of erosive and ulcerative lesions in the gastric mucosa of rats induced by stress

37. O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY

38. Relationship between alcohol consumption and adverse childhood experiences in college students–A cross-sectional study

39. Is Slovakia Almost a Hepatitis D Free Country?

41. Inactivity and fatty liver disease

Catalog

Books, media, physical & digital resources